Princess Margaret Cancer Centre

Kelsie Thu

Understanding resistance to PLK4/TTK inhibitors in breast cancer

Breast

Brad Wouters

Targeting hypoxia in pancreatic cancer through the unfolded protein response

Pancreas

Ian Tannock

Phase II clinical trial of pantoprazole and docetaxel for men with metastatic castration-resistant prostate cancer

Prostate

Madhur Nayan

Outcomes of Progression on Surveillance for Clinical Stage I Nonseminomatous Germ Cell Tumours

Testis

Surgery / Surgical oncology

Michael Velec

Magnetic Resonance Imaging-Guided Radiotherapy for Cervix Cancer Response Monitoring and Treatment Adaptation

Cervix uteri

Brent Williams

Immunotherapy of leukemic stem cells

Leukaemia

Jérôme Fortin

Genetic and functional dissection of PTEN tumor suppressor activity in high-grade ovarian serous carcinoma

Ovary

Donna Reece

Expediting Patient-Oriented Research in Canada: Development of Myeloma Canada Research Network (MCRN)

Multiple myeloma and immunoproliferative diseases

Gregory Chen

Development of the MetaGx computational platform for meta-analysis of cancer molecular subtypes

Melanoma of skin All cancers but non-melanoma skin cancer

Shabbir Alibhai

An RCT and economic analysis of three exercise delivery methods in men with prostate cancer on ADT

Prostate

Aaron David Schimmer

Targeting the mitochondrial proteasome, ClpP, in AML

Leukaemia

Aaron David Schimmer

Inhibiting oncogenic kinases to target metabolism in AML

Leukaemia